Managing ALK+ NSCLC while Ensuring Long-Term Safety of the Patients

Join Prof. Jessica Lin as she explores key strategies for managing ALK+ NSCLC while prioritizing long-term patient safety

Speaker : Prof. Jessica Lin

CDK4/6 Inhibitors in Extending Overall Survival in HR+/HER2- aBC Patients in Clinical Trial and Real World

Explore how CDK4/6 inhibitors improve overall survival in HR+/HER2- advanced breast cancer patients with Dr. Anju Malhotra.

Speakers : Dr. Anju Malhotra

Exploring Best Possible Treatment Strategies in Advanced Urothelial Carcinoma- A Panel Discussion

Explore advanced urothelial carcinoma treatment strategies with Dr. Nagender Sharma. Discover immunotherapy, targeted therapies, and personalized approaches in this expert-led oncology discussion.

Speakers : Dr Nagendra Sharma

Exploring the Hospitalization Burden in Refractory and Relapsed ALL

Explore the hospitalization burden, healthcare impact, and resource demands in patients with relapsed or refractory acute lymphoblastic leukemia (ALL).

Speakers : Dr Nitin Gupta ,Dr Isha Kaul ,Dr Riyaz Ahmed

Understanding Early Relapse in B-cell ALL: Rates, Risks, and Common Sites

Learn about early relapse in B-cell ALL, including relapse rates within the first year, key risk factors, and the most common sites like bone marrow and CNS.

Speakers : Dr Nitin Gupta ,Dr Isha Kaul ,Dr Riyaz Ahmed

From Relapse to Remission : Chasing the Invisible and Redefining Long-Term Survival in Adult R/R B-Cell ALL

Exploring novel therapies and redefining long-term survival outcomes in adult relapsed/refractory B-cell ALL through precision and immunotherapy.

Speakers : Dr Nitin Gupta ,Dr Isha Kaul ,Dr Riyaz Ahmed

From Relapse to Remission: Mapping the Treatment Journey in Adult R/R-Cell ALL - Part 2

Explore optimal first-salvage therapies for adult R/R B-Cell ALL with high disease burden, advancing remission and personalized treatment.

Speakers : Dr Nitin Gupta ,Dr Isha Kaul ,Dr Riyaz Ahmed

From Relapse to Remission Mapping the Treatment Journey in Adult R R B Cell ALL The Critical Goal of MRD

xplore MRD-guided therapies in adult R/R B-ALL, with insights on CAR-T, blinatumomab, and personalized strategies for achieving long-term remission.

Speakers : Dr Nitin Gupta ,Dr Isha Kaul ,Dr Riyaz Ahmed

Redefining Treatment Pathways in Relapsed/Refractory Adult B-Cell ALL

Discover groundbreaking treatments offering new hope for adults with relapsed B-cell ALL. Explore the latest advances, therapies, and strategies transforming outcomes in this challenging leukemia.

Speakers : Dr Riyaz Ahmed ,Dr Isha Kaul ,Dr Nitin Gupta

Unmet Needs in ALK Positive NSCLC- The Challenges in the Current Care

Explore the unmet needs in ALK-positive NSCLC with Dr. Vamshi Krishna M as he discusses current challenges, treatment gaps, and future directions in lung cancer care.

Speakers : Dr. Vamsi Krishna M

Exploring Potentials of Lorlatinib: The Third Generation ALK-TKI Through CROWN Trial

Explore the revolutionary potential of Lorlatinib, a third-generation ALK-TKI, through the CROWN trial with Dr. Vamshi Krishna M.

Speakers : Dr. Vamsi Krishna M


Recommended News For You

A single-cell analysis reveals a distinctive immunosuppressive tumor microenvironment in kidney cancer brain metastases.

Health of Myeloma Patient's Marriage Tied to Recovery After Transplant

How 7,000 steps a day could help reduce your risk of cancer

Infection tied to one-fourth of deaths with lower-risk myelodysplastic syndromes

FDA Panel Supports More Clarity in NSCLC Perioperative Immunotherapy Trials

Study finds that AI is better at forecasting the risk of developing cancer.

Financial hardship for cancer survivors due to high-cost immunotherapies, especially for blood cancer patients

Recommended Articles For You

Cancer Staging: Updates, Clinical Insights, and Educational Resources for Medical Professionals 

How EPCORITAMAB is Revolutionizing the Treatment of Cancer 

Potential of Device-Assisted Therapy in Non-Muscle-Invasive Bladder Cancer 

Feline Anemia: Diagnosis and Treatment with Focus on Rasburicase Complications 
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

New guidelines for radiation therapy for HPV-associated head and neck cancer

2.

Review looks at potential treatment targets in the tumor microenvironment.

3.

Even when they are not paying attention, children are still learning.

4.

The Benefits of Exercise for Substance Use Disorders.

5.

The top three drugs for multiple myeloma treatment upfront are four.

1.

The New Era of Oncology: Key Updates and Clinical Insights

2.

Everything You Need to Know About RDW-CV: A Comprehensive Guide 

3.

Decoding Granular Cell Tumor: What You Need to Know

4.

Subchorionic Hematoma: Causes, Symptoms, and Treatment 

5.

HCC in Melanoma: Role of HCC Codes and Moderate Whole Body Hyperthermia

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Final Discussion

2.

An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Conclusion

3.

Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Conclusion

4.

Cost Burden/ Burden of Hospitalization For R/R ALL Patients

5.

Navigating the Complexities of Ph Negative ALL - Part XI

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot